doi:10.16150/j.1671-2870.2019.06.001

Abstract

CLC Number:

R715.2

References 46

[1]	Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis[J]. BJOG, 2012, 119(7):778-787. doi: 10.1111/j.1471-0528.2012.03311.x URL
[2]	Hertig A, Berkane N, Lefevre G, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia[J]. Clin Chem, 2004, 50(9):1702-1703. doi: 10.1373/clinchem.2004.036715 URL
[3]	Okwudire EG, Atalabi OM, Ezenwugo UM. The use of uterine artery doppler indices for prediction of pre-eclampsia in Port-Harcourt, Nigeria[J]. Niger Postgrad Med J, 2019, 26(4):223-229. doi: 10.4103/npmj.npmj_54_19 URL
[4]	National Collaborating Centre for Women's and Children's Health (UK). Hypertension in pregnancy: The management of hypertensive disorders during pregnancy[M]. London: RCOG Press, 2010.
[5]	ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy[J]. Obstet Gynecol, 2018, 132(1):e44-e52.
[6]	Chaemsaithong P, Pooh RK, Zheng M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population[J]. Am J Obstet Gynecol, 2019, 221(6):650.
[7]	O'Gorman N, Wright D, Poon LC, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations[J]. Ultrasound Obstet Gynecol, 2017, 49(6):756-760. doi: 10.1002/uog.17455 pmid: 28295782
[8]	Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers[J]. Fetal Diagn Ther, 2013, 33(1):8-15. doi: 10.1159/000341264 pmid: 22906914
[9]	Tan MY, Wright D, Syngelaki A, et al. Comparison of dia-gnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE[J]. Ultrasound Obstet Gynecol, 2018, 51(6):743-750. doi: 10.1002/uog.19039 pmid: 29536574
[10]	Sonek J, Krantz D, Carmichael J, et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volu-me[J]. Am J Obstet Gynecol, 2018, 218(1):126.
[11]	Park FJ, Leung CH, Poon LC, et al. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy[J]. Aust N Z J Obstet Gynaecol, 2013, 53(6):532-539. doi: 10.1111/ajo.12126 URL
[12]	O'Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation[J]. Am J Obstet Gynecol, 2016, 214(1):103.
[13]	Krantz DA, Hallahan TW. Incorporating the probability of competing event(s) into the preeclampsia competing risk algorithm[J]. Am J Obstet Gynecol, 2019, 221(5):533-534. doi: S0002-9378(19)30901-9 pmid: 31306651
[14]	Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622. doi: 10.1056/NEJMoa1704559 URL
[15]	Tenório MB, Ferreira RC, Moura FA, et al. Oral antioxidant therapy for prevention and treatment of preeclampsia: Meta-analysis of randomized controlled trials[J]. Nutr Metab Cardiovasc Dis, 2018, 28(9):865-876. doi: S0939-4753(18)30190-X pmid: 30111493
[16]	Committee on Practice Bulletins—Obstetrics. American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia[J]. Obstet Gynecol, 2019, 133(1):e1-e25.
[17]	Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2018, 13:291-310. doi: S2210-7789(18)30126-0 pmid: 29803330
[18]	Jiang R, Teng Y, Huang Y, et al. Preeclampsia serum-induced collagen I expression and intracellular calcium levels in arterial smooth muscle cells are mediated by the PLC-γ1 pathway[J]. Exp Mol Med, 2014, 46:e115.
[19]	Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4(2):295-306. pmid: 16420554
[20]	Hybiak J, Broniarek I, Kiryczyński G, et al. Aspirin and its pleiotropic application[J]. Eur J Pharmacol, 2020, 866:172762. doi: 10.1016/j.ejphar.2019.172762 URL
[21]	Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2018, 218(3):287-293. doi: 10.1016/j.ajog.2017.11.561 URL
[22]	中国高血压防治指南修订委员会, 高血压联盟中国, 中华医学会心血管病学分会, 等.中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56.
[23]	Spracklen CN, Smith CJ, Saftlas AF, et al. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis[J]. Am J Epidemiol, 2014, 180(4):346-358. doi: 10.1093/aje/kwu145 URL
[24]	Montoro MN, Kjos SL, Chandler M, et al. Insulin resistance and preeclampsia in gestationaldiabetes mellitus[J]. Diabetes Care, 2005, 28(8):1995-2000. pmid: 16043744
[25]	Jin WY, Lin SL, Hou RL, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China[J]. BMC Pregnancy Childbirth, 2016, 16:60. doi: 10.1186/s12884-016-0852-9 URL
[26]	郭晓蒙, 张烨, 王娟, 等. BMI联合血脂对妊娠期高血压及子痫前期的预测价值[J]. 中国妇产科临床杂志, 2019, 20(3):199-201.
[27]	Siddiqui F, Kurbasic A, Lindblad U, et al. Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes: a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes[J]. Metabolism, 2017, 66:1-13. doi: 10.1016/j.metabol.2016.10.001 URL
[28]	Assaf-Balut C, García de la Torre N, Fuentes M, et al. A high adherence to six food targets of the mediterranean diet in the late first trimester is associated with a reduction in the risk of materno-foetal Outcomes: The st. carlos gestational diabetes mellitus prevention study[J]. Nutrients, 2018, 11(1) pii: E66.
[29]	Muñó z Muñóz A, Gómez-Cantarino S, de Dios Aguado MLM, et al. Nutritional habits and levels of physical activity during pregnancy, birth and the postpartum period of women in Toledo (Spain): study protocol for a two-year prospective cohort study (the PrePaN study)[J]. BMJ Open, 2019, 9(7):e029487. doi: 10.1136/bmjopen-2019-029487 URL
[30]	LeFevre N, Krumm E. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy[J]. Am Fam Physician, 2019, 100(7):403-405.
[31]	Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy[J]. Cochrane Database Syst Rev, 2018, 10:CD002252.
[32]	Pels A, Mol BWJ, Singer J, et al. Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (Control of Hypertension in Pregnancy Study)[J]. Hypertension, 2018, 71(6):1170-1177. doi: 10.1161/HYPERTENSIONAHA.117.10689 URL
[33]	Panaitescu AM, Roberge S, Nicolaides KH. Chronic hypertension: effect of blood pressure control on pregnancy outcome[J]. J Matern Fetal Neonatal Med, 2019, 32(5):857-863. doi: 10.1080/14767058.2017.1390742 pmid: 28994336
[34]	Magee LA, Singer J, von Dadelszen P, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372(24):2367-2368.
[35]	Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance[J]. BMJ, 2019, 366:l5119.
[36]	Yokoyama K, Takahashi N, Yada Y, et al. Prolonged maternal magnesium administration and bone metabolism in neonates[J]. Early Hum Dev, 2010, 86:18
[37]	Altman D, Carroli G, Duley L, et al. Do women with pre- eclampsia, their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placeb o-controlled trial[J]. Lancet, 2002, 359(9321):1877-1890. doi: 10.1016/S0140-6736(02)08778-0 URL
[38]	Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia[J]. N Engl J Med 2003; 348:304-11. doi: 10.1056/NEJMoa021180 URL
[39]	Trapani A Jr, Gonçalves LF, Trapani TF, et al. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: A randomized controlled trial[J]. Obstet Gynecol, 2016, 128(2):253-259. doi: 10.1097/AOG.0000000000001518 URL
[40]	Vilchez G, Dai J, Lagos M, et al. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial[J]. J Matern Fetal Neonatal Med, 2018, 31(2):178-183. doi: 10.1080/14767058.2017.1279143 URL
[41]	Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia[J]. Cochrane Database Syst Rev, 2010, 10(11): CD000025.
[42]	Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia[J]. N Engl J Med, 2003, 348:304-311. doi: 10.1056/NEJMoa021180 URL
[43]	Vigil-de Gracia P, Ramirez R, Durán Y, et al. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial[J]. BMC Pregnancy Childbirth, 2017, 17(1):241. doi: 10.1186/s12884-017-1424-3 URL
[44]	Vigil-de Gracia P, Ludmir J, Ng J, et al. Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study[J]. BJOG, 2018, 125(10):1304-1311. doi: 10.1111/1471-0528.15320 URL
[45]	Easterling T, Hebert M, Bracken H, et al. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion[J]. BMC Pregnancy Childbirth, 2018, 18(1):290. doi: 10.1186/s12884-018-1919-6 URL
[46]	Pascoal ACF, Katz L, Pinto MH, et al. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial[J]. Medicine, 2019, 98(32):e16779.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 46

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 425-430.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 419-424.
[3]	HUANG Chen, JING Feng, YANG Zhitao, et al . Exploration and practice of construction of nursing management system in shelter hospital [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 286-290.
[4]	LIANG Jing, HUANG Chen, JIANG Yan, et al . Management strategy of nursing for prevention and control of COVID-19 in emergency infusion room [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 281-285.
[5]	ZHANG Hong, ZHU Mengmeng, et al . Safety nursing for eating in the elderly during the COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 277-280.
[6]	ZHOU Jianping, YANG Zhenhua, WANG Yichen, et al . Practice and thinking of the medical team of the elderly medical assistance center in the prevention and control of COVID-19 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 265-269.
[7]	ZHA Qinghua, WANG Xiaoning, ZHANG Yin, et al . Exploration and practice of nucleic acid sampling outside hospital during the epidemic period of COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 229-233.
[8]	YU Ping, QIU Weiyu, WANG Xu, et al . Practice and exploration of drug security management in large shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 221-224.
[9]	JIANG Yan, LIN Wei, HUANG Chen, et al . Exploration and practice of emergency supplies management mode in emergency department under COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 212-215.
[10]	TANG Jie, MA Longxin, CAO Qing, et al . Study on the construction of smart shelter hospital based on new generation information technology [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 196-204.
[11]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[12]	MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 184-188.
[13]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[14]	DING Ning, CHEN Shikai, MENG Jun, DAI Jing, JIN Peipei, et al . Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(Omicron) and the negative conversion cycle in infected patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 169-173.
[15]	YANG Zhitao, CHEN Ying, JING Feng, XIE Zhihui, ZHANG Yibo, SHANG Hanbin, LIN Jingsheng, WU Wenjuan, GU Zhidong, BI Yufang, CHEN Erzhen. Practice and Exploration on the construction of medical affairs management system in large Fangcang hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 154-159.